Dekorationsartikel gehören nicht zum Leistungsumfang.
The End of the Beginning
Cancer, Immunity, and the Future of a Cure
Buch von Michael Kinch
Sprache: Englisch

25,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 1-2 Wochen

Kategorien:
Beschreibung

For the first time since a 5th century Greek physician gave the name "cancer" (karkinos, in Greek) to a deadly disease first described in Egyptian Papyri, the medical world is near a breakthrough that could allow even the most conservative doctors and pragmatic patients to use the other "c word" - cure - in the same sentence as cancer. A remarkable series of events has brought us to this point, thanks in large part to a new ability to more efficiently harness the extraordinary power of the human immune.

The End of the Beginning is a remarkable history of cancer treatment and the evolution of our understanding of its dynamic interplay with the immune system. Through Michael Kinch's personal experience as a cancer researcher at Washington University and the head of the oncology programme at a leading biotechnology company, we witness the incredible accumulation of breakthrough science and its rapid translation into life-saving technologies that have begun to dramatically increase the quality and quantity of life for cancer patients.

Expanding upon Kinch's own remarkable projects to encompass the vaccines being deployed to eliminate cervical cancer, the development of cancer-specific "smart bombs" in the form of monoclonal antibodies, cellular therapies and checkpoint inhibitors-The End of the Beginning reveals the incredible transformation of cancer treatment happening today. Kinch details the remarkable history of people, science, technology and disease and presents thrilling next-generation technologies that hold the promise to eliminate cancer for some, and perhaps ultimately, for all.

For the first time since a 5th century Greek physician gave the name "cancer" (karkinos, in Greek) to a deadly disease first described in Egyptian Papyri, the medical world is near a breakthrough that could allow even the most conservative doctors and pragmatic patients to use the other "c word" - cure - in the same sentence as cancer. A remarkable series of events has brought us to this point, thanks in large part to a new ability to more efficiently harness the extraordinary power of the human immune.

The End of the Beginning is a remarkable history of cancer treatment and the evolution of our understanding of its dynamic interplay with the immune system. Through Michael Kinch's personal experience as a cancer researcher at Washington University and the head of the oncology programme at a leading biotechnology company, we witness the incredible accumulation of breakthrough science and its rapid translation into life-saving technologies that have begun to dramatically increase the quality and quantity of life for cancer patients.

Expanding upon Kinch's own remarkable projects to encompass the vaccines being deployed to eliminate cervical cancer, the development of cancer-specific "smart bombs" in the form of monoclonal antibodies, cellular therapies and checkpoint inhibitors-The End of the Beginning reveals the incredible transformation of cancer treatment happening today. Kinch details the remarkable history of people, science, technology and disease and presents thrilling next-generation technologies that hold the promise to eliminate cancer for some, and perhaps ultimately, for all.

Über den Autor

Michael Kinch is a professor at Washington University in St. Louis. He is the author of Between Hope and Fear (Pegasus Books), The End of the Beginning (Pegasus Books) and A Prescription for Change (UNC Press). Beyond his current work documenting the sources of innovation responsible for new medicines, he has led cancer research activities at the biotechnology company MedImmune and the development of medicines to prevent pandemic virus outbreaks at Functional Genetics, Inc. He led drug discovery at Yale University before moving to St Louis.
Details
Erscheinungsjahr: 2019
Fachbereich: Chirurgie
Genre: Medizin
Rubrik: Wissenschaften
Medium: Buch
Seiten: 328
Inhalt: Gebunden
ISBN-13: 9781643130255
ISBN-10: 1643130250
Sprache: Englisch
Einband: Gebunden
Autor: Kinch, Michael
Hersteller: Pegasus Books
Maße: 237 x 164 x 34 mm
Von/Mit: Michael Kinch
Erscheinungsdatum: 02.04.2019
Gewicht: 0,477 kg
preigu-id: 121073076
Über den Autor

Michael Kinch is a professor at Washington University in St. Louis. He is the author of Between Hope and Fear (Pegasus Books), The End of the Beginning (Pegasus Books) and A Prescription for Change (UNC Press). Beyond his current work documenting the sources of innovation responsible for new medicines, he has led cancer research activities at the biotechnology company MedImmune and the development of medicines to prevent pandemic virus outbreaks at Functional Genetics, Inc. He led drug discovery at Yale University before moving to St Louis.
Details
Erscheinungsjahr: 2019
Fachbereich: Chirurgie
Genre: Medizin
Rubrik: Wissenschaften
Medium: Buch
Seiten: 328
Inhalt: Gebunden
ISBN-13: 9781643130255
ISBN-10: 1643130250
Sprache: Englisch
Einband: Gebunden
Autor: Kinch, Michael
Hersteller: Pegasus Books
Maße: 237 x 164 x 34 mm
Von/Mit: Michael Kinch
Erscheinungsdatum: 02.04.2019
Gewicht: 0,477 kg
preigu-id: 121073076
Warnhinweis